Vis enkel innførsel

dc.contributor.authorAas, Christer Frode
dc.contributor.authorVold, Jørn Henrik
dc.contributor.authorSkurtveit, Svetlana
dc.contributor.authorOdsbu, Ingvild
dc.contributor.authorChalabianloo, Fatemeh
dc.contributor.authorØkland, Jan-Magnus
dc.contributor.authorLeiva, Rafael Alexander Mo
dc.contributor.authorVickerman, Peter
dc.contributor.authorJohansson, Kjell Arne
dc.contributor.authorFadnes, Lars T.
dc.date.accessioned2023-05-08T10:40:46Z
dc.date.available2023-05-08T10:40:46Z
dc.date.created2020-09-29T20:59:06Z
dc.date.issued2020
dc.identifier.citationBMJ Open. 2020, 10:e036355 (8), 1-9.
dc.identifier.issn2044-6055
dc.identifier.urihttps://hdl.handle.net/11250/3066979
dc.language.isoeng
dc.titleOn the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: A prospective cohort study from 2013 to 2017
dc.typePeer reviewed
dc.typeJournal article
dc.description.versionpublishedVersion
dc.source.pagenumber1-9
dc.source.volume10:e036355
dc.source.journalBMJ Open
dc.source.issue8
dc.identifier.doi10.1136/bmjopen-2019-036355
dc.identifier.cristin1835176
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel